Phase II Trial of Weekly Intravenous Gemcitabine With Continuous Infusion Fluorouracil in Patients With Metastatic Renal Cell Cancer

I. Rini, Brian; J. Vogelzang, Nicholas; Dumas, M; L. Wade, James; Taber, David; M. Stadler, Walter

doi:10.1200/jco.2000.18.12.2419

Public

Phase II Trial of Weekly Intravenous Gemcitabine With Continuous Infusion Fluorouracil in Patients With Metastatic Renal Cell Cancer

Published in Journal of Clinical Oncology • Jun 12, 2000

Authors:

Brian I. Rini

Nicholas J. Vogelzang

M Dumas

Abstract

PURPOSE: To determine the clinical response rate of the combination of weekly intravenous (IV) gemcitabine with continuous infusion fluorouracil (5-FU) in patients with metastatic renal cell carcinoma (RCC). PATIENTS AND METHODS: Between June 1998 and February 1999, 41 patients with metastatic RCC w...

Subject

Medicine

Gemcitabine

Mucositis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!